CAITLIN JENNINGS: Open Payments
NPI 1083109300 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 71 payments from 8 companies in 2025. Trend: 2023 $840 · 2024 $984 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $290 |
| Neurocrine BioSciences, Inc. | 15 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $200 |
| Otsuka America Pharmaceutical, Inc. | 7 | $150 |
| Alkermes, Inc. | 8 | $149 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| Lundbeck LLC | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, ARISTADA, REXULTI, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
